Neutrophil-specific targeting of STAT3 impairs tumor progression via the expansion of cytotoxic CD8+ T cells



Summary

Targeting STAT3 specifically in neutrophils, a type of white blood cell, significantly hinders tumor progression, according to this research. The mechanism behind this involves a boosted presence and activity of cytotoxic CD8+ T cells, immune cells crucial for directly killing cancer cells. By selectively suppressing STAT3 in neutrophils, the study suggests a novel approach to enhance anti-tumor immunity through the expansion and activation of these cancer-killing T cells. This indicates that modifying neutrophil function, rather than directly targeting cancer cells, can be a viable immunotherapy strategy.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!